Novogenia AG

€6.35As of Sun 8 Nov 2026, 12:00 UTC
MUN:7V0Healthcare
Country Germany
PE (Fwd) •••
TSR 5Y CAGR 26.56%
Div yield 8.86%
ROE —
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.27
PE TTM —
TSR TTM 4.29%
Mkt cap €76.20M
ROIC (18.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€8.12
27.80%
(41.05%)
Hold 6|2|3|9|5
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.09
0.09
0.09
0.08
12.18%
(0.12%)
(2.62%)
(1.48%)
Revenue€M
5.919
5.982
6.340
6.563
6.59%
6.60%
9.85%
11.90%
Peers (US$84.89M)
Cap (US$)
PE
39.01M
—
Capital
TTM
5Y
10Y
Leveragex
0.145
0.017
0.015
EBIT/Intx
1.137
0.204
0.199
Own earn%
(4.42)
170.13
155.81
Sh yield%
24.87
31.43
34.74
Owners
Insiders/Inst%
8.02
70.92
Short interest%
3.88
SBC / revenue%
2.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
24–32
$1 testx
0.1
Incr. ROIC%
6